Two Sigma Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Buy |
389,000
+354,300
| +1,021% | +$9.43M | 0.01% | 1353 |
|
|
2025
Q4 | $864K | Buy |
+34,700
| New | +$875K | ﹤0.01% | 3035 |
|
|
2022
Q1 | – | Sell |
-154,200
| Closed | -$9.11M | – | 3911 |
|
|
2021
Q4 | $9.11M | Buy |
154,200
+90,700
| +143% | +$4.49M | 0.02% | 847 |
|
|
2021
Q3 | $2.73M | Sell |
63,500
-128,900
| -67% | -$5.71M | 0.01% | 1693 |
|
|
2021
Q2 | $7.53M | Sell |
192,400
-935,700
| -83% | -$36.4M | 0.02% | 971 |
|
|
2021
Q1 | $40.9M | Buy |
+1,128,100
| New | +$40.1M | 0.11% | 219 |
|
|
2020
Q4 | – | Sell |
-8,959
| Closed | -$312K | – | 3653 |
|
|
2020
Q3 | $312K | Sell |
8,959
-31,198
| -78% | -$1.09M | ﹤0.01% | 2560 |
|
|
2020
Q2 | $1.25M | Sell |
40,157
-285,213
| -88% | -$9.69M | 0.01% | 1386 |
|
|
2020
Q1 | $10.1M | Buy |
325,370
+59,340
| +22% | +$2.02M | 0.08% | 251 |
|
|
2019
Q4 | $9.89M | Sell |
266,030
-892,316
| -77% | -$31.8M | 0.03% | 624 |
|
|
2019
Q3 | $39.5M | Buy |
1,158,346
+765,415
| +195% | +$27.8M | 0.13% | 206 |
|
|
2019
Q2 | $16.1M | Sell |
392,931
-152,725
| -28% | -$6.06M | 0.05% | 413 |
|
|
2019
Q1 | $22M | Buy |
545,656
+507,290
| +1,322% | +$20.3M | 0.07% | 360 |
|
|
2018
Q4 | $1.59M | Sell |
38,366
-179,601
| -82% | -$7.46M | 0.01% | 1366 |
|
|
2018
Q3 | $9.11M | Sell |
217,967
-562,942
| -72% | -$21.7M | 0.02% | 676 |
|
|
2018
Q2 | $26.9M | Buy |
780,909
+32,042
| +4% | +$1.09M | 0.08% | 321 |
|
|
2018
Q1 | $25.2M | Buy |
748,867
+439,413
| +142% | +$15.1M | 0.08% | 285 |
|
|
2017
Q4 | $10.6M | Sell |
309,454
-26,034
| -8% | -$888K | 0.03% | 586 |
|
|
2017
Q3 | $11.4M | Sell |
335,488
-550,926
| -62% | -$17.7M | 0.04% | 473 |
|
|
2017
Q2 | $28.2M | Sell |
886,414
-982,223
| -53% | -$31M | 0.1% | 253 |
|
|
2017
Q1 | $60.7M | Buy |
1,868,637
+1,367,671
| +273% | +$43.1M | 0.2% | 117 |
|
|
2016
Q4 | $15.4M | Sell |
500,966
-919,615
| -65% | -$28.1M | 0.06% | 397 |
|
|
2016
Q3 | $45.6M | Buy |
1,420,581
+14,756
| +1% | +$493K | 0.17% | 138 |
|
|
2016
Q2 | $47M | Buy |
1,405,825
+1,033,763
| +278% | +$33M | 0.2% | 112 |
|
|
2016
Q1 | $10.5M | Sell |
372,062
-92,752
| -20% | -$2.65M | 0.05% | 427 |
|
|
2015
Q4 | $14.2M | Buy |
464,814
+418,438
| +902% | +$13.2M | 0.07% | 315 |
|
|
2015
Q3 | $1.38M | Sell |
46,376
-150,722
| -76% | -$4.83M | 0.01% | 1017 |
|
|
2015
Q2 | $6.27M | Sell |
197,098
-133,436
| -40% | -$4.35M | 0.03% | 619 |
|
|
2015
Q1 | $10.9M | Buy |
+330,534
| New | +$10.5M | 0.05% | 445 |
|
Other funds holding PFE
VCM
VPM
Two Sigma Investments's PFE Position: Q1 2026 in Review
Two Sigma Investments reduced its Pfizer (PFE) stake by 90% in Q1 2026, selling an estimated $49.4M and leaving 212,100 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.
Two Sigma Investments first reported a position in PFE in Q3 2013 and has held it in 41 quarters since. The position peaked at $271M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Two Sigma Investments held 212,100 shares of Pfizer worth $5.96M as of Q1 2026.
- Two Sigma Investments sold 1,856,008 Pfizer shares in Q1 2026, an estimated $49.4M.
- Pfizer made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1816 holding.
- Two Sigma Investments first reported a position in Pfizer in Q3 2013 and has held it in 41 quarters since.
- Two Sigma Investments's Pfizer position peaked at $271M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.